- Home
- GLDD vs ORIC Comparison
GLDD vs ORIC Comparison
Compare GLDD & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLDD
- ORIC
- Stock Information
- Founded
- GLDD 1890
- ORIC 2014
- Country
- GLDD United States
- ORIC United States
- Employees
- GLDD N/A
- ORIC N/A
- Industry
- GLDD Military/Government/Technical
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- GLDD Industrials
- ORIC Health Care
- Exchange
- GLDD Nasdaq
- ORIC Nasdaq
- Market Cap
- GLDD 829.6M
- ORIC 750.6M
- IPO Year
- GLDD 2006
- ORIC 2020
- Fundamental
- Price
- GLDD $11.94
- ORIC $8.50
- Analyst Decision
- GLDD Buy
- ORIC Strong Buy
- Analyst Count
- GLDD 1
- ORIC 9
- Target Price
- GLDD $14.00
- ORIC $18.75
- AVG Volume (30 Days)
- GLDD 445.8K
- ORIC 499.8K
- Earning Date
- GLDD 11-05-2024
- ORIC 11-12-2024
- Dividend Yield
- GLDD N/A
- ORIC N/A
- EPS Growth
- GLDD N/A
- ORIC N/A
- EPS
- GLDD 0.87
- ORIC N/A
- Revenue
- GLDD $741,648,000.00
- ORIC N/A
- Revenue This Year
- GLDD $31.75
- ORIC N/A
- Revenue Next Year
- GLDD $7.25
- ORIC N/A
- P/E Ratio
- GLDD $13.68
- ORIC N/A
- Revenue Growth
- GLDD 33.74
- ORIC N/A
- 52 Week Low
- GLDD $6.40
- ORIC $6.33
- 52 Week High
- GLDD $12.83
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- GLDD 52.24
- ORIC 37.50
- Support Level
- GLDD $10.25
- ORIC $10.06
- Resistance Level
- GLDD $12.83
- ORIC $11.11
- Average True Range (ATR)
- GLDD 0.49
- ORIC 0.81
- MACD
- GLDD -0.04
- ORIC -0.05
- Stochastic Oscillator
- GLDD 65.31
- ORIC 13.00
About GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.